THE COMPANY

Liansa Pharma Consulting AB was founded in 2015 offering consultancy services for the pharmaceutical industry in southern Sweden and Denmark. Since 2020, we focus on services within the CMC-Regulatory Affairs area. Liansa Pharma Consulting AB is supporting clients ranging from local start-ups to mid-sized pharmaceutical companies

SERVICES

Authoring and review of MAA/NDA documentation, Communication with Competent Authorities, Authoring and review
of Phase 1-3 IMPD and IND documentation
, Technical and strategic support on drug substance and formulation development from the early stages of development and further on.

Outsourcing of Drug Substance and Drug Product manufacturing (Requests for Proposals,
Technical and quality evaluation, Supply and quality agreements, Technical support).

Implementation and review of Quality Management Systems.
Evaluation/audits of contract manufacturers (GMP). 

COMPETENCE

Hans Wännman received a M.Sc. in Chemical Engineering from the Faculty of Engineering at Lund University in 1990.
Hans has over 25 years of experience from drug development in the pharmaceutical industry.
He started his industrial career within the field of analytical chemistry and has since worked with
formulation development, manufacturing outsourcing and authoring of quality documentation in various
positions. Since 2015, he is an independent consultant and owner of Liansa Pharma Consulting AB.

HANS WÄNNMAN

HANS WÄNNMAN


LIANSA PHARMA CONSULTING AB

Apelvägen 40, 262 65 Ängelholm, Sweden
Phone: +46 707 280 189
info@liansa.se